Day: October 18, 2023

Automotive Electric Fuel Pumps Market Set to Soar Past USD 21.24 Billion by 2030

Written by Customer Service on October 18, 2023. Posted in Mergers And Acquisitions.

The global Automotive Electric Fuel Pumps market size is expected to reach USD 21.24 billion by 2030 and exhibit a CAGR of 5.70% in the forecast period (2023−2030), according to Skyquest’s latest research report. The growing demand for electric vehicles, increasing fuel efficiency requirements and emission regulations, rising consumer preference for cleaner and greener technologies, improving battery technology and range of electric vehicles, cost reduction and economies of scale in electric fuel pump production, are fueling the market’s growth. Westford USA, Oct. 18, 2023 (GLOBE NEWSWIRE) — According to SkyQuest’s latest global research of the Automotive Electric Fuel Pumps market, increasing adoption of brushless electric fuel pumps, integration of electric fuel pumps with intelligent control systems, development...

Titan Medical Announces Change in Auditor

Written by Customer Service on October 18, 2023. Posted in Public Companies.

TORONTO, Ontario, Oct. 18, 2023 (GLOBE NEWSWIRE) — Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD; OTC: TMDIF), a medical technology company, announces that it has changed its auditor from BDO Canada LLP (the “Former Auditor”) to MNP LLP (the “Successor Auditor”) effective October 10, 2023. At the request of the Company, the Former Auditor resigned as auditor of the Company on October 10, 2023 and the board of directors of the Company appointed the Successor Auditor as the new auditor until the next annual general meeting of shareholders of the Company. The Company confirms that there have been no reservations or modified opinions in the Former Auditor’s reports for the two most recently completed financial years or for any period subsequent to the most recently completed period for which an audit report was issued. The...

Ramsay Sante : Annual Results at the end of June 2023

Written by Customer Service on October 18, 2023. Posted in Earnings Releases And Operating Results.

PRESS RELEASE Paris, 18th October 2023 Annual results at the end of June 2023 Group revenue increased by 9.3% to €4.7bn supported by positive activity volume growth in all geographies and recent acquisitions in the Nordic countries. Revenue growth on a like-for-like basis of 7.0%. Group EBITDA decreased by 5.6% to €621.4m, impacted by lower subsidies, high salary and procurement inflation and staff shortage challenges. Group share of net result after tax of €49.4m or 1.1% of revenue more than halved compared to the prior year of €118.4m from lower operating result and increased cost of debt. Cost control measures reinforced to address current economic headwinds impacting the sector, to pursue our “Yes We Care 2025” strategy implementing global patient pathways, and to maintain our leadership as a European integrated care...

Innofactor Plc: Share Repurchase 18.10.2023

Written by Customer Service on October 18, 2023. Posted in Public Companies.

Innofactor Plc Announcement 18.10.2023 Innofactor Plc: Share Repurchase 18.10.2023 In the Helsinki Stock Exchange Trade date 18.10.2023 Bourse trade Buy Share IFA1V Amount 4,100 SharesAverage price/ share 1.0583 EURTotal cost 4,339.03 EUR Innofactor Plc now holds a total of 318 962 sharesincluding the shares repurchased on 18.10.2023 On behalf of Innofactor Plc Nordea Bank Oyj Janne Sarvikivi Sami Huttunen Additional information: Sami Ensio, CEO Innofactor Plc Tel. +358 50 584 2029 sami.ensio@innofactor.com www.innofactor.com AttachmentInnofactor_18.10_trades

Talenom Plc: Managers’ Transactions – Erik William Tahkola

Written by Customer Service on October 18, 2023. Posted in Public Companies.

Talenom Plc, Managers’ Transactions 18 October 2023 at 18:30 EEST Talenom Plc: Managers’ Transactions – Erik William Tahkola_____________________________________ Person subject to the notification requirementName: Erik William TahkolaPosition: Member of the Board/Deputy memberIssuer: Talenom OyjLEI: 7437008E4R0N45B8J675 Notification type: INITIAL NOTIFICATIONReference number: 41038/5/4____________________________________________Transaction date: 2023-10-16Outside a trading venueInstrument type: SHAREISIN: FI4000153580Nature of transaction: GIFT,DONATION OR INHERITANCE (RECEIVED) Transaction details(1): Volume: 20000 Unit price: 0 EUR Aggregated transactions (1):Volume: 20000 Volume weighted average price: 0 EUR

Talenom Plc: Managers’ Transactions – Harri Tahkola

Written by Customer Service on October 18, 2023. Posted in Public Companies.

Talenom Plc, Managers’ Transactions 18 October 2023 at 18:30 EEST Talenom Plc: Managers’ Transactions – Harri Tahkola____________________________________________ Person subject to the notification requirementName: Harri TahkolaPosition: Member of the Board/Deputy memberIssuer: Talenom OyjLEI: 7437008E4R0N45B8J675 Notification type: INITIAL NOTIFICATIONReference number: 41018/5/6____________________________________________ Transaction date: 2023-10-16Outside a trading venueInstrument type: SHAREISIN: FI4000153580Nature of transaction: GIFT,DONATION OR INHERITANCE (MADE) Transaction details(1): Volume: 20000 Unit price: 0 EUR(2): Volume: 20000 Unit price: 0 EUR(3): Volume: 20000 Unit price: 0 EUR(4): Volume: 20000 Unit price: 0 EUR(5): Volume: 20000 Unit price: 0 EUR(6): Volume: 20000 Unit price: 0 EUR Aggregated transactions...

NexImmune Announces 1-for-25 Reverse Stock Split

Written by Customer Service on October 18, 2023. Posted in Public Companies.

GAITHERSBURG, Md., Oct. 18, 2023 (GLOBE NEWSWIRE) — NexImmune, Inc. (Nasdaq: NEXI) (the “Company”) a biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by directing the function of antigen-specific T cells in oncology, autoimmune and infectious diseases, today announced that the Board of Directors and stockholders of the Company approved a 1-for-25 reverse stock split of the Company’s common stock at a special meeting of the Company held on October 17, 2023. The reverse stock split will take effect after the close of trading on The Nasdaq Capital Market at 5:00 p.m. Eastern Time, on Wednesday, October 18, 2023. The Company’s common stock will open for trading under a new CUSIP number 65344D 208 on The Nasdaq Capital Market on October 19, 2023, on a split-adjusted...

TCM GROUP A/S releases preliminary Q3 numbers and downgrades outlook

Written by Customer Service on October 18, 2023. Posted in Public Companies.

COMPANY ANNOUNCEMENT No. 181/2023 Tvis, 18. October 2023 TCM GROUP A/S releases preliminary Q3 numbers and downgrades outlook. TCM Group releases the preliminary financial numbers for Q3 2023 and downgrades the outlook for the financial year 2023. The downgrade is due to weaker trading conditions, increased provisions for accounts receivables, and a correction of estimates on transit-fees received from 3rd party suppliers pertaining to the financial year as a whole, including the first two quarters. Revenue in Q3 was DKK 258 million compared to DKK 265 million in Q3 last year, equal to a decline of 2.8%, where it should be noted that Aubo Production is consolidated in the financial figures from 3 July 2023 onwards. Adjusted EBIT in the quarter was DKK 3 million, with a material negative impact from the correction of third-party...

Aerostructures Market Set to Soar Past USD 101.01 Billion by 2030

Written by Customer Service on October 18, 2023. Posted in Mergers And Acquisitions.

The global Aerostructures market size is expected to reach USD 101.01 billion by 2030 and exhibit a CAGR of 7.86% in the forecast period (2023−2030), according to Skyquest’s latest research report. The increasing demand for lightweight and fuel-efficient aircraft, growing air passenger traffic, rising defense budgets, advancements in composite materials and manufacturing techniques, expanding commercial aviation sector, adoption of additive manufacturing in aerostructures production, increasing focus on reducing aircraft emissions, modernization and retrofitting of existing aircraft, expanding aerospace and defense industry in emerging economies, are fueling the market’s growth. Westford USA, Oct. 18, 2023 (GLOBE NEWSWIRE) — According to SkyQuest’s latest global research of the Aerostructures market, increased...

PD-1 And PD-L1 Inhibitors Market to Surpass 129.36 Billion by 2030 Drives Due to Immunotherapy Advancements

Written by Customer Service on October 18, 2023. Posted in Mergers And Acquisitions.

SkyQuest projects that the PD-1 and PD-L1 inhibitors market will attain a USD 129.36 billion value by 2030, with a CAGR of 17.5% over the forecast period (2023-2030). The PD-1 and PD-L1 inhibitors market is fueled by rapid developments in immunotherapy, leveraging these inhibitors to enhance the body’s immune response against cancer. This innovation drives market growth as more precise and effective treatment options emerge. Westford, USA, Oct. 18, 2023 (GLOBE NEWSWIRE) — According to SkyQuest, escalating global cancer incidences propel the demand for PD-1 and PD-L1 inhibitors. These inhibitors offer a promising avenue for patients seeking personalized and potent therapies, contributing to the PD-1 and PD-L1 inhibitors market’s expansion with their ability to target various cancer types. Browse In-Depth TOC on the...

Day: October 18, 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice